Follicular lymphoma-like B cells of uncertain significance (in situ follicular lymphoma) may infrequently progress, but precedes follicular lymphoma, is associated with other overt lymphomas and mimics follicular lymphoma in flow cytometric studies

Haematologica

Volumn 98, Issue 10, 2013, Pages 1571-1580

  Pillai, Raju K ^a,b   Surti, Urvashi ^a   Swerdlow, Steven H ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; KAPPA OPIATE RECEPTOR; PREDNISONE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE TRANSLOCATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPH FOLLICLE; LYMPH NODE BIOPSY; LYMPHOID TISSUE; MALE; RETROSPECTIVE STUDY; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED;

EID: 84884949944     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.085506     Document Type: Article

References (40)

1. Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, Jaffe ES. In situ localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood. 2002;99(9):3376-82.
2. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-32.
3. Fend F, Cabecadas J, Gaulard P, Jaffe ES, Kluin P, Kuzu I, et al. Early lesions in lymphoid neoplasia. J Hematopathol. 2012; 5(3):169-99.
4. Montes-Moreno S, Castro Y, Rodriguez-Pinilla SM, Garcia JF, Mollejo M, Castillo ME, et al. Intrafollicular neoplasia/in situ follicular lymphoma: review of a series of 13 cases. Histopathology. 2010;56(5):658-62.
5. Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, Pittaluga S, et al. Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood. 2011; 118(11):2976-84.
6. Lee JC, Hoehn D, Schecter J, Murty VV, Mansukhani MM, Alobeid B, et al. Lymphoid follicle colonization by Bcl-2 bright+ CD10+ B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma. Hum Pathol. 2013 [Epub ahead of print].
7. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360(7):659-67.
8. Cook JR, Craig FE, Swerdlow SH. Bcl-2 expression by multicolor flow cytometric analysis assists in the diagnosis of follicular lymphoma in lymph node and bone marrow. Am J Clin Pathol. 2003;119(1):145-51.
9. Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol. 2013; 37(3):323-32.
10. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008.
11. Henopp T, Quintanilla-Martinez L, Fend F, Adam P. Prevalence of follicular lymphoma in situ in consecutively analysed reactive lymph nodes. Histopathology. 2011; 59(1):139-42.
12. Howlader N, Noone A, Krapcho M, Neyman N, Aminou R, Altekruse S, et al., editors. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2009_pops 09/, based on November 2011 SEER data submission, posted to the SEER web site. April 2012.
13. Ray S, Craig FE, Swerdlow SH. Abnormal patterns of antigenic expression in follicular lymphoma: a flow cytometric study. Am J Clin Pathol. 2005;124(4):576-83.
14. Bala R, Warnke R, Natkunam Y. Expanding the Morphologic Spectrum of Follicular Lymphoma In Situ: 13 Examples Including In Situ Grade 3 and BCL2-Negative Cases. Modern Pathology (USCAP Annual meeting abstract). 2012;25(S2):324A.
15. Bonzheim I, Salaverria I, Haake A, Gastl G, Adam P, Siebert R, et al. A unique case of follicular lymphoma provides insights to the clonal evolution from follicular lymphoma in situ to manifest follicular lymphoma. Blood. 2011;118(12):3442-4.
16. Carbone A, Tibiletti MG, Zannier L, Selva A, Sulfaro S, Gloghini A. A unique case of extranodal DLBCL sharing genetic abnormalities with a synchronous ileal lym phoma exhibiting immunoarchitectural features of in situ follicular lymphoma. Am J Hematol. 2012;87(12):E134-5.
17. Carbone A, Santoro A. How I treat: diagnosing and managing "in situ" lymphoma. Blood. 2011;117(15):3954-60.
18. Howard MT, Dufresne S, Swerdlow SH, Cook JR. Follicular lymphoma of the spleen: multiparameter analysis of 16 cases. Am J Clin Pathol. 2009;131(5):656-62.
19. Li JN, Zhang WY, Tang Y, Li GD, Dong DD. In situ follicular lymphoma with progressive transformation of the germinal centers confirmed by laser capture microdissection, IGH gene rearrangement analysis, and fluorescence in situ hybridization for t(14;18). Hum Pathol. 2012;43(1):138-43.
20. Cheung MC, Bailey D, Pennell N, Imrie KR, Berinstein NL, Amato D, et al. In situ localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical BCL-2/IGH fusion gene in blood and lymph node. Leukemia. 2009; 23(6):1176-9.
21. Schuler F, Dolken L, Hirt C, Kiefer T, Berg T, Fusch G, et al. Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int J Cancer. 2009;124(4):958-63.
22. Dolken G, Illerhaus G, Hirt C, Mertelsmann R. BCL-2/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin. Oncol. 1996;14(4):1333-44.
23. Limpens J, Stad R, Vos C, Devlaam C, Dejong D, Vanommen GJB, et al. Lymphoma-associated translocation t(14;18) in blood B-cells of normal individuals. Blood. 1995;85(9):2528-36.
24. Roulland S, Lebailly P, Roussel G, Briand M, Cappellen D, Pottier D, et al. BCL-2/JH translocation in peripheral blood lymphocytes of unexposed individuals: lack of seasonal variations in frequency and molecular features. Int J Cancer. 2003;104(6):695-8.
25. Roulland S, Faroudi M, Mamessier E, Sungalee S, Salles G, Nadel B. Early steps of follicular lymphoma pathogenesis. Advances Immunol. 2011;111:1-46.
26. Roulland S, Navarro J-M, Grenot P, Milili M, Agopian J, Montpellier B, et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med. 2006; 203(11): 2425-31.
27. Roulland S, Sungalee J, Morgado E, Mamessier E, Gregoire E, Monvoisin C, et al. Iterative Germinal Center Re-Entries of Memory B-Cells with t(14;18) Translocation and Early Steps of Follicular Lymphoma Progression. Blood (ASH Annual Meeting Abstracts). 2012;120:150.
28. Yoshida M, Ichikawa A, Miyoshi H, Takeuchi M, Kimura Y, Nino D, et al. High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma. Pathol Int. 2012;62(8):518-24.
29. Marafioti T, Hummel M, Foss HD, Laumen H, Korbjuhn P, Anagnostopoulos I, et al. Hodgkin and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood. 2000;95(4):1443-50.
30. Nakamura N, Ohshima K, Abe M, Osamura Y. Demonstration of chimeric DNA of bcl-2 and immunoglobulin heavy chain in follicular lymphoma and subsequent Hodgkin lymphoma from the same patient. J Clin Exp Hematop. 2007;47(1):9-13.
31. Tsang P, Pan L, Cesarman E, Tepler J, Knowles DM. A distinctive composite lymphoma consisting of clonally related mantle cell lymphoma and follicle center cell lymphoma. Hum Pathol. 1999;30(8):988-92.
32. Kussick SJ, Kalnoski M, Braziel RM, Wood BL. Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. Am J Clin Pathol. 2004;121(4):464-72.
33. Ota Y, Izutsu K, Ota H, Nishida A, Ishiwata K, Tsuji M, et al. "Early Lesion" of follicular lymphoma (FL) precedes clinically overt FL: A retrospective study of lymph nodes (LNs) obtained at surgery with LNs dissection for preceding cancer. Blood (ASH Annual Meeting Abstracts). 2012;120:2716.
34. Adam P, Schiefer AI, Prill S, Henopp T, Quintanilla-Martinez L, Bosmuller HC, et al. Incidence of preclinical manifestations of mantle cell lymphoma and mantle cell lymphoma in situ in reactive lymphoid tissues. Mod Pathol. 2012;25(12):1629-36.
35. Ghia P, Caligaris-Cappio F. Monoclonal Bcell lymphocytosis: right track or red herring? Blood. 2012;119(19):4358-62.
36. Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, et al. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol. 2010;151(2):152-8.
37. Rawstron AC. Monoclonal B-cell lymphocytosis. Hematology Am Soc Hematol Educ Program. 2009:430-9.
38. Rawstron AC, Yuille MR, Fuller J, Cullen M, Kennedy B, Richards SJ, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 2002;100(7):2289-90.
39. Carvajal-Cuenca A, Sua LF, Silva NM, Pittaluga S, Royo C, Song JY, et al. In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior. Haematologica. 2012; 97(2):270-8.
40. Racke F, Simpson S, Christian B, Blum K, Hasserjian R, Zhao W. Evidence of Long Latency Periods Prior to Development of Mantle Cell Lymphoma (ASH Meeting Abstract). Blood. 2010;116(21):147.